{
  "targets": [
    {"name": "Genentech", "region": "NorCal", "city": "South San Francisco", "lat": 37.6563, "lng": -122.4077, "focus": "Oncology, Immunology", "funding": "Roche Subsidiary", "employees": "14-19K", "stage": "Commercial", "priority": "strategic", "isCustomer": true},
    {"name": "Denali Therapeutics", "region": "NorCal", "city": "South San Francisco", "lat": 37.6550, "lng": -122.4030, "focus": "Neurodegeneration", "funding": "Public", "employees": "364", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Caribou Biosciences", "region": "NorCal", "city": "Berkeley", "lat": 37.8715, "lng": -122.2710, "focus": "CRISPR CAR-T", "funding": "Public", "employees": "200+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Altos Labs", "region": "NorCal", "city": "San Francisco", "lat": 37.7749, "lng": -122.4194, "focus": "Longevity/Rejuvenation", "funding": "$3B", "employees": "300+", "stage": "Research", "priority": "high", "isCustomer": false},
    {"name": "Numerion Labs", "region": "NorCal", "city": "San Francisco", "lat": 37.7760, "lng": -122.4180, "focus": "AI Drug Discovery", "funding": "$174M", "employees": "100+", "stage": "Platform", "priority": "medium", "isCustomer": false, "note": "Formerly Atomwise - rebranded 2025"},
    {"name": "64x Bio", "region": "NorCal", "city": "Brisbane", "lat": 37.6855, "lng": -122.4001, "focus": "Gene Therapy Manufacturing", "funding": "$55M", "employees": "50+", "stage": "Growth", "priority": "high", "isCustomer": false, "news": "AAV Apex Suite launched Jun 2025"},
    {"name": "89bio", "region": "NorCal", "city": "San Francisco", "lat": 37.7853, "lng": -122.4005, "focus": "NASH/Liver Disease", "funding": "Public", "employees": "100+", "stage": "Phase 2", "priority": "medium", "isCustomer": false},
    {"name": "Calico Life Sciences", "region": "NorCal", "city": "South San Francisco", "lat": 37.6531, "lng": -122.4010, "focus": "Aging Research", "funding": "Alphabet", "employees": "367", "stage": "Research", "priority": "medium", "isCustomer": false},
    {"name": "GRAIL", "region": "NorCal", "city": "Menlo Park", "lat": 37.4520, "lng": -122.1817, "focus": "Multi-Cancer Detection", "funding": "Public", "employees": "1500", "stage": "Commercial", "priority": "strategic", "isCustomer": false, "news": "PATHFINDER 2 results Oct 2025 - 7x cancer detection improvement"},
    {"name": "Sutro Biopharma", "region": "NorCal", "city": "South San Francisco", "lat": 37.6545, "lng": -122.4090, "focus": "ADCs/Bispecifics", "funding": "Public", "employees": "150-200", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "3T Biosciences", "region": "NorCal", "city": "South San Francisco", "lat": 37.6548, "lng": -122.4050, "focus": "Immunotherapy", "funding": "Series A", "employees": "11-50", "stage": "Preclinical", "priority": "watch", "isCustomer": false},
    {"name": "Allogene Therapeutics", "region": "NorCal", "city": "South San Francisco", "lat": 37.6555, "lng": -122.4085, "focus": "Allogeneic CAR-T", "funding": "Public", "employees": "201-500", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Akero Therapeutics", "region": "NorCal", "city": "South San Francisco", "lat": 37.6560, "lng": -122.4075, "focus": "Metabolic Diseases", "funding": "Public", "employees": "56", "stage": "Phase 3", "priority": "high", "isCustomer": false},
    {"name": "Anagenex", "region": "NorCal", "city": "San Francisco", "lat": 37.7780, "lng": -122.4130, "focus": "AI + DEL Discovery", "funding": "Series A", "employees": "20+", "stage": "Platform", "priority": "medium", "isCustomer": false},
    {"name": "Cellares", "region": "NorCal", "city": "South San Francisco", "lat": 37.6533, "lng": -122.4065, "focus": "Cell Therapy Manufacturing (IDMO)", "funding": "$257M Series D", "employees": "200+", "stage": "Growth", "priority": "strategic", "isCustomer": false, "news": "FDA AMT designation Apr 2025, BMS $380M deal, IPO prep, new CCO Dec 2025"},
    {"name": "Deep Genomics", "region": "NorCal", "city": "San Francisco", "lat": 37.7795, "lng": -122.4160, "focus": "AI RNA Therapeutics", "funding": "$180M", "employees": "100+", "stage": "Clinical", "priority": "high", "isCustomer": false, "news": "REPRESS AI model launched May 2025"},
    {"name": "Cofactor Genomics", "region": "NorCal", "city": "San Francisco", "lat": 37.7810, "lng": -122.4100, "focus": "RNA Diagnostics", "funding": "Series C", "employees": "50+", "stage": "Commercial", "priority": "medium", "isCustomer": false},
    {"name": "Color Health", "region": "NorCal", "city": "Burlingame", "lat": 37.5775, "lng": -122.3477, "focus": "Population Genomics", "funding": "$278M", "employees": "400+", "stage": "Commercial", "priority": "medium", "isCustomer": false},
    {"name": "Gritstone Oncology", "region": "NorCal", "city": "Emeryville", "lat": 37.8313, "lng": -122.2850, "focus": "Cancer Immunotherapy", "funding": "Public", "employees": "51-200", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "Freenome", "region": "NorCal", "city": "South San Francisco", "lat": 37.6540, "lng": -122.4055, "focus": "Multi-Cancer Detection AI", "funding": "SPAC 2025", "employees": "300+", "stage": "Commercial", "priority": "strategic", "isCustomer": false, "news": "Going public via SPAC, Roche partnership Nov 2025, Exact Sciences license, new CEO Apr 2025"},
    {"name": "Kyverna Therapeutics", "region": "NorCal", "city": "Emeryville", "lat": 37.8320, "lng": -122.2860, "focus": "Autoimmune CAR-T", "funding": "Public", "employees": "100+", "stage": "Clinical", "priority": "high", "isCustomer": false, "news": "First-mover in autoimmune cell therapy, new CFO Jun 2025"},
    {"name": "Insitro", "region": "NorCal", "city": "South San Francisco", "lat": 37.6558, "lng": -122.4070, "focus": "ML Drug Discovery", "funding": "$400M+", "employees": "150+", "stage": "Platform", "priority": "high", "isCustomer": false, "news": "Founded by Daphne Koller, AI governance leader"},
    {"name": "Recursion Pharmaceuticals", "region": "NorCal", "city": "Salt Lake City", "lat": 40.7608, "lng": -111.8910, "focus": "AI Drug Discovery", "funding": "Public", "employees": "500+", "stage": "Clinical", "priority": "high", "isCustomer": false, "news": "Leading AI drug discovery platform"},
    
    {"name": "Amgen", "region": "LA", "city": "Thousand Oaks", "lat": 34.1706, "lng": -118.8376, "focus": "Oncology, Inflammation", "funding": "Public", "employees": "26K", "stage": "Commercial", "priority": "strategic", "isCustomer": true},
    {"name": "Kite Pharma", "region": "LA", "city": "Santa Monica", "lat": 34.0195, "lng": -118.4912, "focus": "CAR-T Immunotherapy", "funding": "Gilead", "employees": "1000+", "stage": "Commercial", "priority": "strategic", "isCustomer": true},
    {"name": "ImmunityBio", "region": "LA", "city": "Culver City", "lat": 34.0211, "lng": -118.3965, "focus": "Immunotherapy", "funding": "Public", "employees": "500+", "stage": "Clinical", "priority": "strategic", "isCustomer": false},
    {"name": "NantHealth", "region": "LA", "city": "Culver City", "lat": 34.0215, "lng": -118.3970, "focus": "AI Healthcare", "funding": "Public", "employees": "200+", "stage": "Commercial", "priority": "high", "isCustomer": false},
    {"name": "Fulgent Genetics", "region": "LA", "city": "Temple City", "lat": 34.1072, "lng": -118.0579, "focus": "Genomic Testing", "funding": "Public", "employees": "1000+", "stage": "Commercial", "priority": "high", "isCustomer": false},
    {"name": "Applied VR", "region": "LA", "city": "Los Angeles", "lat": 34.0522, "lng": -118.2437, "focus": "VR Therapeutics", "funding": "$36M", "employees": "100+", "stage": "Commercial", "priority": "medium", "isCustomer": false},
    {"name": "CytoDyn", "region": "LA", "city": "Los Angeles", "lat": 34.0525, "lng": -118.2440, "focus": "HIV/Oncology", "funding": "Public", "employees": "30+", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "Emmaus Medical", "region": "LA", "city": "Torrance", "lat": 33.8358, "lng": -118.3406, "focus": "Sickle Cell Disease", "funding": "Public", "employees": "50+", "stage": "Commercial", "priority": "medium", "isCustomer": false},

    {"name": "National Resilience", "region": "SanDiego", "city": "San Diego", "lat": 32.8789, "lng": -117.2359, "focus": "Biomanufacturing CDMO", "funding": "$825M (Oct 2025)", "employees": "2000+", "stage": "Commercial", "priority": "strategic", "isCustomer": false, "news": "New CEO Dec 2024, major facility expansion, CARGO Therapeutics partnership"},
    {"name": "Gilead Sciences", "region": "SanDiego", "city": "Oceanside", "lat": 33.1959, "lng": -117.3795, "focus": "Antivirals, Oncology", "funding": "Public", "employees": "14K+", "stage": "Commercial", "priority": "strategic", "isCustomer": true},
    {"name": "Neurocrine Biosciences", "region": "SanDiego", "city": "San Diego", "lat": 32.8820, "lng": -117.2100, "focus": "Neurology", "funding": "Public", "employees": "1500+", "stage": "Commercial", "priority": "strategic", "isCustomer": true},
    {"name": "Enovis Corp", "region": "SanDiego", "city": "Carlsbad", "lat": 33.1581, "lng": -117.3506, "focus": "Medical Devices", "funding": "Public", "employees": "500+", "stage": "Commercial", "priority": "medium", "isCustomer": true},
    {"name": "Artiva Biotherapeutics", "region": "SanDiego", "city": "San Diego", "lat": 32.8760, "lng": -117.2300, "focus": "NK Cell Therapies", "funding": "Series B", "employees": "100+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Epic Sciences", "region": "SanDiego", "city": "San Diego", "lat": 32.8830, "lng": -117.2110, "focus": "Liquid Biopsy", "funding": "Series F", "employees": "200+", "stage": "Commercial", "priority": "high", "isCustomer": false},
    {"name": "RayzeBio", "region": "SanDiego", "city": "San Diego", "lat": 32.8810, "lng": -117.2200, "focus": "Radiopharmaceuticals", "funding": "$358M IPO", "employees": "150+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Element Biosciences", "region": "SanDiego", "city": "San Diego", "lat": 32.8795, "lng": -117.2280, "focus": "DNA Sequencing", "funding": "Series C", "employees": "200+", "stage": "Commercial", "priority": "high", "isCustomer": false},
    {"name": "Aspen Neuroscience", "region": "SanDiego", "city": "San Diego", "lat": 32.8850, "lng": -117.2150, "focus": "Parkinson's Cell Therapy", "funding": "$147.5M", "employees": "80+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Fate Therapeutics", "region": "SanDiego", "city": "San Diego", "lat": 32.8840, "lng": -117.2190, "focus": "iPSC Cell Therapies", "funding": "Public", "employees": "500+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Crinetics Pharmaceuticals", "region": "SanDiego", "city": "San Diego", "lat": 32.8775, "lng": -117.2310, "focus": "Rare Endocrine", "funding": "Public", "employees": "200+", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "Human Longevity", "region": "SanDiego", "city": "San Diego", "lat": 32.8862, "lng": -117.2180, "focus": "Genomics + AI Health", "funding": "$300M", "employees": "100+", "stage": "Commercial", "priority": "medium", "isCustomer": false},
    {"name": "Belharra Therapeutics", "region": "SanDiego", "city": "San Diego", "lat": 32.8745, "lng": -117.2265, "focus": "Chemoproteomic Discovery", "funding": "$130M", "employees": "50+", "stage": "Platform", "priority": "high", "isCustomer": false},
    {"name": "Inovio Pharmaceuticals", "region": "SanDiego", "city": "San Diego", "lat": 32.8865, "lng": -117.2135, "focus": "DNA Immunotherapy", "funding": "Public", "employees": "200+", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "BioDuro-Sundia", "region": "SanDiego", "city": "San Diego", "lat": 32.8735, "lng": -117.2340, "focus": "CRDMO Services", "funding": "Advent Intl", "employees": "3000+", "stage": "Commercial", "priority": "strategic", "isCustomer": false},
    {"name": "NanoCellect Biomedical", "region": "SanDiego", "city": "San Diego", "lat": 32.8805, "lng": -117.2220, "focus": "Cell Sorting", "funding": "Series D", "employees": "50+", "stage": "Commercial", "priority": "medium", "isCustomer": false},
    {"name": "Debut Biotech", "region": "SanDiego", "city": "San Diego", "lat": 32.8780, "lng": -117.2290, "focus": "Cell-free Manufacturing", "funding": "Series A", "employees": "30+", "stage": "Growth", "priority": "watch", "isCustomer": false},
    {"name": "Prometheus Biosciences", "region": "SanDiego", "city": "San Diego", "lat": 32.8845, "lng": -117.2165, "focus": "Precision Medicine IBD", "funding": "Public", "employees": "100+", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "Boundless Bio", "region": "SanDiego", "city": "San Diego", "lat": 32.8752, "lng": -117.2275, "focus": "Oncology (ecDNA)", "funding": "Public", "employees": "80+", "stage": "Clinical", "priority": "high", "isCustomer": false, "news": "Extrachromosomal DNA focus, novel oncology approach"},
    {"name": "Cartography Biosciences", "region": "SanDiego", "city": "San Francisco", "lat": 37.7755, "lng": -122.4175, "focus": "Precision Therapeutics", "funding": "$50M+", "employees": "50+", "stage": "Platform", "priority": "high", "isCustomer": false, "news": "CEO Kevin Parker named BioSpace 40 Under 40 Oct 2025"},

    {"name": "Adaptive Biotechnologies", "region": "PNW", "city": "Seattle", "lat": 47.6205, "lng": -122.3493, "focus": "Immune Medicine", "funding": "$125M", "employees": "800+", "stage": "Commercial", "priority": "strategic", "isCustomer": false},
    {"name": "Sana Biotechnology", "region": "PNW", "city": "Seattle", "lat": 47.6150, "lng": -122.3410, "focus": "Gene/Cell Therapy", "funding": "$700M+", "employees": "400+", "stage": "Clinical", "priority": "high", "isCustomer": false, "news": "⚠️ MONITOR: Securities fraud class action filed May 2025"},
    {"name": "Tune Therapeutics", "region": "PNW", "city": "Seattle", "lat": 47.6180, "lng": -122.3450, "focus": "Epigenetic Silencing", "funding": "$175M Series B", "employees": "100+", "stage": "Phase 1", "priority": "strategic", "isCustomer": false, "news": "New CEO John McHutchison (ex-Gilead) Mar 2025, Hong Kong trial approved Jan 2025"},
    {"name": "Outpace Bio", "region": "PNW", "city": "Seattle", "lat": 47.6220, "lng": -122.3380, "focus": "AI-Powered CAR-T", "funding": "$144M", "employees": "80+", "stage": "IND-Enabling", "priority": "high", "isCustomer": false},
    {"name": "Aurion Biotech", "region": "PNW", "city": "Seattle", "lat": 47.6195, "lng": -122.3520, "focus": "Corneal Cell Therapy", "funding": "$120M", "employees": "60+", "stage": "Commercial (Japan)", "priority": "high", "isCustomer": false},
    {"name": "Umoja Biopharma", "region": "PNW", "city": "Seattle", "lat": 47.6165, "lng": -122.3470, "focus": "In Vivo CAR-T", "funding": "$100M", "employees": "150+", "stage": "Phase 1", "priority": "high", "isCustomer": false, "news": "Nona Biosciences collaboration expanded Nov 2025"},
    {"name": "A-Alpha Bio", "region": "PNW", "city": "Seattle", "lat": 47.6235, "lng": -122.3355, "focus": "Protein Engineering", "funding": "$14.5M DOD", "employees": "50+", "stage": "Platform", "priority": "medium", "isCustomer": false},
    {"name": "TwinStrand Biosciences", "region": "PNW", "city": "Seattle", "lat": 47.6140, "lng": -122.3505, "focus": "NGS/MRD Detection", "funding": "$83M patent", "employees": "100+", "stage": "Commercial", "priority": "medium", "isCustomer": false},
    {"name": "Lumen Bioscience", "region": "PNW", "city": "Seattle", "lat": 47.6255, "lng": -122.3420, "focus": "Oral Antibodies", "funding": "$16M DOD", "employees": "80+", "stage": "Phase 2", "priority": "medium", "isCustomer": false},
    {"name": "Sound Pharmaceuticals", "region": "PNW", "city": "Seattle", "lat": 47.6120, "lng": -122.3540, "focus": "Hearing Loss", "funding": "$4.2M NIH", "employees": "30+", "stage": "Phase 3", "priority": "medium", "isCustomer": false},
    {"name": "Alpine Immune Sciences", "region": "PNW", "city": "Seattle", "lat": 47.6175, "lng": -122.3385, "focus": "Immunotherapies", "funding": "Public", "employees": "200+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Eliem Therapeutics", "region": "PNW", "city": "Seattle", "lat": 47.6210, "lng": -122.3435, "focus": "Neuropsychiatry", "funding": "Public", "employees": "50+", "stage": "Clinical", "priority": "medium", "isCustomer": false},
    {"name": "ProfoundBio", "region": "PNW", "city": "Seattle", "lat": 47.6160, "lng": -122.3485, "focus": "ADCs", "funding": "$312M", "employees": "100+", "stage": "Clinical", "priority": "high", "isCustomer": false},
    {"name": "Arzeda", "region": "PNW", "city": "Seattle", "lat": 47.6245, "lng": -122.3395, "focus": "Enzyme Design AI", "funding": "$14.1M NSF", "employees": "80+", "stage": "Platform", "priority": "medium", "isCustomer": false},
    {"name": "Accipiter Biosciences", "region": "PNW", "city": "Seattle", "lat": 47.6188, "lng": -122.3460, "focus": "AI Protein Design", "funding": "$12.7M", "employees": "20+", "stage": "Discovery", "priority": "watch", "isCustomer": false}
  ],
  "existingCustomers": [
    {"name": "Genentech", "region": "NorCal", "city": "South San Francisco", "lat": 37.6563, "lng": -122.4077, "revenue": "$1.8M", "gp": "42%"},
    {"name": "Amgen", "region": "LA", "city": "Thousand Oaks", "lat": 34.1706, "lng": -118.8376, "revenue": "$1.75M", "gp": "21.1%"},
    {"name": "Kite Pharma", "region": "LA", "city": "Santa Monica", "lat": 34.0195, "lng": -118.4912, "revenue": "$2.08M", "gp": "19.9%"},
    {"name": "Gilead Sciences", "region": "SanDiego", "city": "Oceanside", "lat": 33.1959, "lng": -117.3795, "revenue": "$2.13M", "gp": "22%"},
    {"name": "Neurocrine Biosciences", "region": "SanDiego", "city": "San Diego", "lat": 32.8820, "lng": -117.2100, "revenue": "$890K", "gp": "48%"},
    {"name": "Enovis Corp", "region": "SanDiego", "city": "Carlsbad", "lat": 33.1581, "lng": -117.3506, "revenue": "$773K", "gp": "18.3%"}
  ],
  "acquiredCompanies": [
    {"name": "Capstan Therapeutics", "region": "SanDiego", "city": "San Diego", "acquiredBy": "AbbVie", "acquiredDate": "August 2025", "note": "Lead asset CPTX2309 now in Phase 1"},
    {"name": "Poseida Therapeutics", "region": "SanDiego", "city": "San Diego", "acquiredBy": "Roche", "acquiredDate": "2025", "note": "Now part of Roche Group"}
  ],
  "lastUpdated": "2026-02-03",
  "researchNotes": "Atomwise rebranded to Numerion Labs. Sana Biotechnology has active securities fraud litigation - monitor closely."
}
